You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 294 No. 19, November 16, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Correction
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The IDEAL Cholesterol

Lower Is Better

Christopher P. Cannon, MD

JAMA. 2005;294:2492-2494.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Three decades ago, the primary results of the Multiple Risk Factor Intervention Trial (MRFIT) were published in JAMA; that trial attempted to demonstrate benefits from lowering cholesterol (with diet) and managing other known risk factors for reducing cardiovascular morbidity and mortality.1 Since then, multiple trials have shown cardiovascular benefit from lowering cholesterol, especially low-density lipoprotein cholesterol (LDL-C).2-3 However, as of 1993, no trial had demonstrated a clear reduction in total mortality and, thus, debate still raged as to whether it was beneficial to reduce cholesterol.3

This changed when Pedersen and colleagues4 reported the landmark Scandinavian Simvastatin Survival Study (4S), which demonstrated that use of simvastatin, 20 to 40 mg/d, produced a highly significant 30% reduction in total mortality, in addition to reductions in myocardial infarction (MI) and the need for coronary revascularization. Subsequent trials expanded the benefit of treating broader groups of patients with statins,5 . . . [Full Text of this Article]

Author Affiliations: TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Statins, Diet, and Low Cholesterol
Dario Giugliano and Katherine Esposito
JAMA. 2006;295(21):2479.
EXTRACT | FULL TEXT  

Statins, Diet, and Low Cholesterol
Rohit Arora and Saravanan Balamuthusamy
JAMA. 2006;295(21):2479.
EXTRACT | FULL TEXT  

Statins, Diet, and Low Cholesterol—Reply
Christopher P. Cannon
JAMA. 2006;295(21):2479-2480.
EXTRACT | FULL TEXT  

Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?
Dario Giugliano, Maria Ida Maiorino, and Katherine Esposito
Arch Intern Med. 2009;169(20):1930.
EXTRACT | FULL TEXT  

RELATED ARTICLE

High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized Controlled Trial
Terje R. Pedersen, Ole Faergeman, John J. P. Kastelein, Anders G. Olsson, Matti J. Tikkanen, Ingar Holme, Mogens Lytken Larsen, Fredrik S. Bendiksen, Christina Lindahl, Michael Szarek, John Tsai, and for the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group
JAMA. 2005;294(19):2437-2445.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Low-Carbohydrate Diet and Blood Lipid Levels: How Good and How Fast?
Giugliano et al.
Arch Intern Med 2009;169:1930-1930.
FULL TEXT  

Intensity of Statin Therapy in Relation to Myocardial Ischemia, Troponin T Release, and Clinical Cardiac Outcome in Patients Undergoing Major Vascular Surgery
Feringa et al.
J Am Coll Cardiol 2007;50:1649-1656.
ABSTRACT | FULL TEXT  

Biases in the Identification of Risk Factor Thresholds and J-Curves
Marschner et al.
Am J Epidemiol 2007;166:824-831.
ABSTRACT | FULL TEXT  

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis
Qian et al.
J. Lipid Res. 2007;48:1488-1498.
ABSTRACT | FULL TEXT  

The gap between theory and practice: what do the trials tell us?
Pedersen
Eur Heart J Suppl 2006;8:F10-F16.
ABSTRACT | FULL TEXT  

Reducing risk by raising HDL-cholesterol: the evidence
Drexel
Eur Heart J Suppl 2006;8:F23-F29.
ABSTRACT | FULL TEXT  

Statins, diet, and low cholesterol.
Giugliano and Esposito
JAMA 2006;295:2479-2479.
FULL TEXT  

Statins, diet, and low cholesterol.
Arora and Balamuthusamy
JAMA 2006;295:2479-2479.
FULL TEXT  

The Changing Face of Dyslipidemia Therapies
Rochester and Cooke
Journal of Pharmacy Practice 2006;19:79-93.
ABSTRACT  

Coronary Artery Calcium: Should We Rely on This Surrogate Marker?
Redberg
Circulation 2006;113:336-337.
FULL TEXT  

Intensive LDL Lowering After MI
Journal Watch Cardiology 2005;2005:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.